Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephrat Levy-Lahad

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidenceEphrat Levy-Lahad
Nature Genetics|April 30, 2010
Fanconi anemia and breast cancer susceptibility meet againEphrat Levy-Lahad
The New England Journal of Medicine|October 27, 2020
Hiding in Plain Sight - Somatic Mutation in Human DiseaseEphrat Levy-Lahad, Mary-Claire King
Science (New York, N.Y.)|October 25, 2003
Cancer. A risky business--assessing breast cancer riskEphrat Levy-Lahad, Sharon E Plon
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 23, 2008
Response to ACMG guideline: carrier screening in individuals of Ashkenazi Jewish decentEphrat Levy-Lahad, Shachar Zuckerman, Michal Sagi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2022
Germline Pathogenic Variants in <i>BRCA1</i> and <i>BRCA2</i>: Malignancies Beyond Female Breast and Ovarian CancersSari Lieberman, Hadar Goldvaser, Ephrat Levy-Lahad
Scientific Reports|July 28, 2018
Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target PathwaysHadar Vinograd-Byk, Paul Renbaum, Ephrat Levy-Lahad
JAMA|February 4, 2015
Proposed shift in screening for breast cancer--replyMary-Claire King, Amnon Lahad, Ephrat Levy-Lahad
Journal of the National Cancer Institute|January 1, 2015
Precision medicine meets public health: population screening for BRCA1 and BRCA2Ephrat Levy-Lahad, Amnon Lahad, Mary-Claire King
The New England Journal of Medicine|August 2, 2014
Mutant ADA2 in vasculopathiesReeval Segel, Mary-Claire King, Ephrat Levy-Lahad
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidenceEphrat Levy-Lahad
Nature Genetics|April 30, 2010
Fanconi anemia and breast cancer susceptibility meet againEphrat Levy-Lahad
The New England Journal of Medicine|October 27, 2020
Hiding in Plain Sight - Somatic Mutation in Human DiseaseEphrat Levy-Lahad, Mary-Claire King
Science (New York, N.Y.)|October 25, 2003
Cancer. A risky business--assessing breast cancer riskEphrat Levy-Lahad, Sharon E Plon
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 23, 2008
Response to ACMG guideline: carrier screening in individuals of Ashkenazi Jewish decentEphrat Levy-Lahad, Shachar Zuckerman, Michal Sagi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2022
Germline Pathogenic Variants in <i>BRCA1</i> and <i>BRCA2</i>: Malignancies Beyond Female Breast and Ovarian CancersSari Lieberman, Hadar Goldvaser, Ephrat Levy-Lahad
Scientific Reports|July 28, 2018
Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target PathwaysHadar Vinograd-Byk, Paul Renbaum, Ephrat Levy-Lahad
JAMA|February 4, 2015
Proposed shift in screening for breast cancer--replyMary-Claire King, Amnon Lahad, Ephrat Levy-Lahad
Journal of the National Cancer Institute|January 1, 2015
Precision medicine meets public health: population screening for BRCA1 and BRCA2Ephrat Levy-Lahad, Amnon Lahad, Mary-Claire King
The New England Journal of Medicine|August 2, 2014
Mutant ADA2 in vasculopathiesReeval Segel, Mary-Claire King, Ephrat Levy-Lahad
Pageof 14